Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Dec;35(12):2467–2472. doi: 10.1128/aac.35.12.2467

Evaluation of vancomycin for therapy of adult pneumococcal meningitis.

P F Viladrich 1, F Gudiol 1, J Liñares 1, R Pallarés 1, I Sabaté 1, G Rufí 1, J Ariza 1
PMCID: PMC245414  PMID: 1810180

Abstract

The emergence of pneumococci resistant to penicillin and other agents prompted us to evaluate intravenous vancomycin for the therapy of pneumococcal meningitis, which has an overall mortality of 30%. Eleven consecutive adult patients with cerebrospinal fluid (CSF)-culture-proven pneumococcal meningitis and positive initial CSF Gram stain were given intravenous vancomycin (usual dosage, 7.5 mg/kg every 6 h for 10 days). The MBCs of vancomycin ranged from 0.25 to 0.5 micrograms/ml. Early adjunctive therapy with intravenous dexamethasone, mannitol, and sodium phenytoin was also instituted. After 48 h of therapy, all 11 patients showed a satisfactory clinical response, although the CSF culture remained positive in one case; median trough CSF and serum vancomycin levels were 2 and 5.1 micrograms/ml, respectively, and trough CSF bactericidal titers ranged from less than 1:2 to 1:16. On day 3, one patient died of acute heart failure. Four patients had clinical failure at on days 4 (two patients), 7 (one), and 8 (one) of therapy; they all immediately responded to a change in antibiotic therapy. The remaining six patients were cured after 10 days of vancomycin therapy. At this point, median peak CSF and serum vancomycin levels were 1.9 and 18.5 micrograms/ml, respectively. A transient alteration of renal function occurred in two patients, and persistent slight hypoacusia occurred in three patients. In summary, 11 adults with pneumococcal meningitis were treated with vancomycin and early adjunctive therapy including dexamethasone. All patients initially improved, and 10 were ultimately cured of the infection. However, four patients experienced a therapeutic failure, which led to a change in vancomycin therapy.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum P. C. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 1987 Aug;6(4):367–377. doi: 10.1007/BF02013089. [DOI] [PubMed] [Google Scholar]
  2. Brady M. T., Kaplan S. L., Taber L. H. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr. 1981 Dec;99(6):924–926. doi: 10.1016/s0022-3476(81)80023-6. [DOI] [PubMed] [Google Scholar]
  3. Buzón L. M., Guerrero A., Romero J., Santamaria J. M., Bouza E. Penicillin-resistant Streptococcus pneumoniae meningitis successfully treated with vancomycin. Eur J Clin Microbiol. 1984 Oct;3(5):442–443. doi: 10.1007/BF02017368. [DOI] [PubMed] [Google Scholar]
  4. Cagigas P., López-Herce J., Díez Enciso M., Ruza F. Meningitis por Streptococcus pneumoniae altamente resistente a la penicilina y no tratable con cefotaxima ni cloramfenicol. Med Clin (Barc) 1985 Dec 7;85(19):814–815. [PubMed] [Google Scholar]
  5. Fenoll A., Martín Bourgon C., Muñz R., Vicioso D., Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis. 1991 Jan-Feb;13(1):56–60. doi: 10.1093/clinids/13.1.56. [DOI] [PubMed] [Google Scholar]
  6. GEORGE R. M., COCHRAN C. P., WHEELER W. E. Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment. Am J Dis Child. 1961 Mar;101:296–304. doi: 10.1001/archpedi.1961.04020040024005. [DOI] [PubMed] [Google Scholar]
  7. Garau J., Linares J., Dominguez C. Chloramphenicol-resistant pneumococci. Lancet. 1981 Jul 18;2(8238):147–148. doi: 10.1016/s0140-6736(81)90324-x. [DOI] [PubMed] [Google Scholar]
  8. Hawley H. B., Gump D. W. Vancomycin therapy of bacterial meningitis. Am J Dis Child. 1973 Aug;126(2):261–264. doi: 10.1001/archpedi.1973.02110190231025. [DOI] [PubMed] [Google Scholar]
  9. Jackson M. A., Shelton S., Nelson J. D., McCracken G. H., Jr Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis. 1984 Mar-Apr;3(2):129–132. doi: 10.1097/00006454-198403000-00010. [DOI] [PubMed] [Google Scholar]
  10. Jacobs M. R., Mithal Y., Robins-Browne R. M., Gaspar M. N., Koornhof H. J. Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob Agents Chemother. 1979 Aug;16(2):190–197. doi: 10.1128/aac.16.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jolley M. E., Stroupe S. D., Schwenzer K. S., Wang C. J., Lu-Steffes M., Hill H. D., Popelka S. R., Holen J. T., Kelso D. M. Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination. Clin Chem. 1981 Sep;27(9):1575–1579. [PubMed] [Google Scholar]
  12. Kadurugamuwa J. L., Hengstler B., Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis. 1989 Jan;159(1):26–34. doi: 10.1093/infdis/159.1.26. [DOI] [PubMed] [Google Scholar]
  13. Kaiser A. B., McGee Z. A. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med. 1975 Dec 11;293(24):1215–1220. doi: 10.1056/NEJM197512112932401. [DOI] [PubMed] [Google Scholar]
  14. Liñares J., Perez J. L., Garau J., Murgui L., Martín R. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. J Antimicrob Chemother. 1984 Apr;13(4):353–359. doi: 10.1093/jac/13.4.353. [DOI] [PubMed] [Google Scholar]
  15. McCracken G. H., Jr, Lebel M. H. Dexamethasone therapy for bacterial meningitis in infants and children. Am J Dis Child. 1989 Mar;143(3):287–289. doi: 10.1001/archpedi.1989.02150150041013. [DOI] [PubMed] [Google Scholar]
  16. Nolan C. M., McAllister C. K., Walters E., Beaty H. N. Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation. J Lab Clin Med. 1978 Jun;91(6):979–988. [PubMed] [Google Scholar]
  17. Plotkin S. A., McKitrick J. C. Nosocomial meningitis of the newborn caused by a flavobacterium. JAMA. 1966 Nov 7;198(6):662–664. [PubMed] [Google Scholar]
  18. Ryan J. L., Pachner A., Andriole V. T., Root R. K. Enterococcal meningitis: combined vancomycin and rifampin therapy. Am J Med. 1980 Mar;68(3):449–451. doi: 10.1016/0002-9343(80)90118-7. [DOI] [PubMed] [Google Scholar]
  19. SWARTZ M. N., DODGE P. R. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. 1. GENERAL CLINICAL FEATURES, SPECIAL PROBLEMS AND UNUSUAL MENINGEAL REACTIONS MIMICKING BACTERIAL MENINGITIS. N Engl J Med. 1965 Apr 15;272:779–CONTD. doi: 10.1056/NEJM196504152721506. [DOI] [PubMed] [Google Scholar]
  20. Scheld W. M., Brodeur J. P. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother. 1983 Jan;23(1):108–112. doi: 10.1128/aac.23.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sutherland G. E., Palitang E. G., Marr J. J., Luedke S. L. Sterilization of Ommaya reservoir by instillation of vancomycin. Am J Med. 1981 Dec;71(6):1068–1070. doi: 10.1016/0002-9343(81)90344-2. [DOI] [PubMed] [Google Scholar]
  22. Tunkel A. R., Wispelwey B., Scheld W. M. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med. 1990 Apr 15;112(8):610–623. doi: 10.7326/0003-4819-112-8-610. [DOI] [PubMed] [Google Scholar]
  23. Viladrich P. F., Gudiol F., Liñares J., Rufi G., Ariza J., Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 1988 May;84(5):839–846. doi: 10.1016/0002-9343(88)90061-7. [DOI] [PubMed] [Google Scholar]
  24. Wenger J. D., Hightower A. W., Facklam R. R., Gaventa S., Broome C. V. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990 Dec;162(6):1316–1323. doi: 10.1093/infdis/162.6.1316. [DOI] [PubMed] [Google Scholar]
  25. Winkelstein J. A. The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis. 1981 Mar-Apr;3(2):289–298. doi: 10.1093/clinids/3.2.289. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES